Elevai Labs Inc
For the period ended Jun 30, 2024. Filed Aug 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 14, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements
Condensed Consolidated Financial Statements of
For the quarterly periods ended June 30, 2024, and 2023
(Unaudited - Expressed in United States Dollars)
Condensed Consolidated Balance Sheets
(Unaudited - Expressed in United States dollar)
| As of: | June 30, 2024 | December 31, 2023 |
|---|---|---|
| ASSETS | ||
| Current Assets | ||
| Cash | $100,034 | $3,326,851 |
| Receivables, net | 29,070 | 36,161 |
| Prepaids and deposits | 923,444 | 1,060,765 |
| Inventory, net | 978,548 | 495,667 |
| Total Current Assets | 2,031,096 | 4,919,444 |
| Deposit | 10,773 | 10,773 |
| Property and equipment, net | 55,751 | 53,119 |
| Intangibles, net | 2,845,066 | - |
| Operating lease right-of-use asset | 137,535 | 206,582 |
| TOTAL ASSETS | $5,080,221 | $5,189,918 |
| LIABILITIES | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | $1,181,441 | $669,375 |
| Customer deposits | 24,314 | 36,693 |
| Due to related parties | 173,648 | 77,127 |
| Current portion of consideration payable | 348,403 | - |
| Current portion of lease liability | 140,063 | 145,000 |
| Derivative liabilities | 67,355 | 369,158 |
| Total Current Liabilities | 1,935,224 | 1,297,353 |
| Consideration payable | 505,361 | - |
| Operating lease liability | - | 65,489 |
| TOTAL LIABILIITES | $2,440,585 | $1,362,842 |
| Commitments and Contingencies | ||
| EQUITY | ||
| Common stock, $0.0001 par value, 300,000,000 shares authorized; 18,892,115 and 17,329,615 shares issued and outstanding as of June 30, 2024, and December 31, 2023, respectively | 1,889 | 1,733 |
| Additional paid-in capital | 12,470,136 | 10,849,031 |
| Accumulated other comprehensive income | 1,242 | 202 |
| Accumulated deficit | (9,833,631) | (7,023,890) |
| TOTAL EQUITY | 2,639,636 | 3,827,076 |
| TOTAL LIABILITIES AND EQUITY | $5,080,221 | $5,189,918 |
Condensed Consolidated Statements of Operations and Comprehensive Loss
(Unaudited - Expressed in United States dollar)
| Three months ended June 30, 2024 | Three months ended June 30, 2023 | Six months ended June 30, 2024 | Six months ended June 30, 2023 | |
|---|---|---|---|---|
| Revenue | $605,529 | 316,530 | 1,220,092 | 459,350 |
| Cost of sales | 166,275 | 108,180 | 335,186 | 152,613 |
| Gross profit | $439,254 | 208,350 | 884,906 | 306,737 |
| Expenses | ||||
| Depreciation and amortization | 2,709 | 2,888 | 5,093 | 5,385 |
| Marketing and promotion | 721,489 | 114,051 | 1,114,527 | 216,727 |
| Consulting fees | 185,443 | 149,723 | 581,569 | 233,687 |
| Office and administrative | 663,956 | 529,950 | 1,542,564 | 964,009 |
| Professional fees | 158,143 | 168,933 | 338,065 | 306,730 |
| Investor relations | 6,377 | 37,452 | 104,622 | 75,720 |
| Research and development | 52,385 | 133,654 | 173,526 | 217,395 |
| Foreign exchange (gain) loss | 244 | 2,374 | 785 | 2,633 |
| Travel and entertainment | 57,121 | 122,655 | 116,229 | 184,170 |
| Total Expenses | $1,847,867 | 1,261,680 | 3,976,980 | 2,206,456 |
| Net loss before other income (expense) | $(1,408,613) | (1,053,330) | (3,092,074) | (1,899,719) |
| Other income (expense) | ||||
| Change in fair value of derivative liabilities | 26,864 | (222,468) | 301,803 | (459,246) |
| Interest expense | (30,806) | (4,409) | (54,343) | (7,045) |
| Interest income | 64 | 349 | 150 | 5,456 |
| Other income | - | - | 34,723 | - |
| Net loss | $(1,412,491) | (1,279,858) | (2,809,741) | (2,360,554) |
| Other comprehensive income (loss) | ||||
| Currency translation adjustment | (141) | 262 | 1,040 | 375 |
| Total comprehensive loss | $(1,412,632) | (1,279,596) | (2,808,701) | (2,360,179) |
| Basic and diluted loss per share | $(0.08) | (0.128) | (0.158) | (0.240) |
| Weighted average shares outstanding | 18,298,572 | 9,976,725 | 17,814,093 | 9,838,599 |
Condensed Consolidated Statements of Changes in Stockholders’ Equity
| Series seed 1 preferred stock · Series seed 2 preferred stock · Series A preferred stock · Common Stock · Additional · Accumulated other | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of shares | Amount | Number of shares | Amount | Number of shares | Amount | Number of shares | Amount | paid-in capital | Accumulated deficit | comprehensive income | Total | |
| # | $ | # | $ | # | $ | # | $ | $ | $ | $ | $ | |
| Balance, April 1, 2023 | 213,730 | 21 | 3,635,252 | 364 | 1,861,799 | 186 | 9,880,975 | 988 | 4,714,674 | (3,803,069) | 224 | 913,388 |
| Private placement | - | - | - | - | - | - | 107,861 | 11 | 323,578 | - | - | 323,589 |
| Share-based compensation | - | - | - | - | - | - | - | - | 109,907 | - | - | 109,907 |
| Net loss for the period | - | - | - | - | - | - | - | - | - | (1,279,858) | - | (1,279,858) |
| Currency translation adjustment | - | - | - | - | - | - | - | - | - | - | 262 | 262 |
| Balance, June 30, 2023 | 213,730 | 21 | 3,635,252 | 364 | 1,861,799 | 186 | 9,988,836 | 999 | 5,148,159 | (5,082,927) | 486 | 67,288 |
| Balance, April 1, 2024 | - | - | - | - | - | - | 17,329,615 | 1,733 | 10,904,370 | (8,421,140) | 1,383 | 2,486,346 |
| Issued for acquisition of intangible assets | - | - | - | - | - | - | 1,562,500 | 156 | 772,247 | - | - | 772,403 |
| Obligation to issue stock for acquisition of intangible assets | - | - | - | - | - | - | - | - | 838,374 | - | - | 838,374 |
| Share-based compensation | - | - | - | - | - | - | - | - | (44,855) | - | - | (44,855) |
| Net loss for the period | - | - | - | - | - | - | - | - | (1,412,491) | - | (1,412,491) | |
| Currency translation adjustment | - | - | - | - | - | - | - | - | - | - | (141) | (141) |
| Balance, June 30, 2024 | - | - | - | - | - | - | 18,892,115 | 1,889 | 12,470,136 | (9,833,631) | 1,242 | 2,639,636 |
Condensed Consolidated Statements of Changes in Stockholders’ Equity
| Series seed 1 preferred stock · Series seed 2 preferred stock · Series A preferred stock · Common Stock · Additional · Accumulated other | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of shares | Amount | Number of shares | Amount | Number of shares | Amount | Number of shares | Amount | paid-in capital | Accumulated deficit | comprehensive income | Total | |
| # | $ | # | $ | # | $ | # | $ | $ | $ | $ | $ | |
| Balance, January 1, 2023 | 213,730 | 21 | 3,635,252 | 364 | 1,861,799 | 186 | 9,568,475 | 957 | 3,852,044 | (2,722,373) | 111 | 1,131,310 |
| Private placement | - | - | - | - | - | - | 357,861 | 36 | 1,073,553 | - | - | 1,073,589 |
| Exercise of stock options | - | - | - | - | - | - | 62,500 | 6 | 37,494 | - | - | 37,500 |
| Share-based compensation | - | - | - | - | - | - | - | - | 185,068 | - | - | 185,068 |
| Net loss for the period | - | - | - | - | - | - | - | - | - | (2,360,554) | - | (2,360,554) |
| Currency translation adjustment | - | - | - | - | - | - | - | - | - | - | 375 | 375 |
| Balance, June 30, 2023 | 213,730 | 21 | 3,635,252 | 364 | 1,861,799 | 186 | 9,988,836 | 999 | 5,148,159 | (5,082,927) | 486 | 67,288 |
| Balance, January 1, 2024 | - | - | - | - | - | - | 17,329,615 | 1,733 | 10,849,031 | (7,023,890) | 202 | 3,827,076 |
| Issued for acquisition of intangible assets | 1,562,500 | 156 | 772,247 | - | - | 772,403 | ||||||
| Obligation to issue stock for acquisition of intangible assets | - | - | - | - | - | - | - | - | 838,374 | - | - | 838,374 |
| Share-based compensation | - | - | - | - | - | - | - | - | 10,484 | - | - | 10,484 |
| Net loss for the period | - | - | - | - | - | - | - | - | - | (2,809,741) | - | (2,809,741) |
| Currency translation adjustment | - | - | - | - | - | - | - | - | - | - | 1,040 | 1,040 |
| Balance, June 30, 2024 | - | - | - | - | - | - | 18,892,115 | 1,889 | 12,470,136 | (9,833,631) | 1,242 | 2,639,636 |
Condensed Consolidated Statements of Cash Flows
For the Six months ended June 30, 2024, and 2023
| June 30, 2024 · June 30, 2023 | ||||
|---|---|---|---|---|
| Operating activities | ||||
| Net loss | $(2,809,741) | $(2,360,554) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation and amortization | 45,960 | 5,825 | ||
| Share-based compensation | 10,484 | 185,068 | ||
| Straight-line rent expense | (1,379) | (1,378) | ||
| Change in fair value of derivative liabilities | (301,803) | 459,246 | ||
| Non-cash interest expense | 42,312 | - | ||
| R&D costs for intangible assets | 39,483 | - | ||
| Changes in operating assets and liabilities: | ||||
| Receivables | 6,958 | (21,480) | ||
| Prepaid expenses and deposits | 137,295 | (183,518) | ||
| Inventory | (482,881) | (247,718) | ||
| Accounts payable and accrued liabilities | 210,111 | 375,053 | ||
| Customer deposits | (12,379) | 75,194 | ||
| Due to related parties | 50,306 | 60,000 | ||
| Cash flows used in operating activities | $(3,104,757) | $(1,654,262) | ||
| Investing activities | ||||
| Purchase of equipment | (9,160) | (11,191) | ||
| Purchase of intangible assets | (112,320) | - | ||
| Cash flows used in investing activities | $(121,480) | $(11,191) | ||
| Financing activities | ||||
| Exercise of stock options | - | 37,500 | ||
| Proceeds from issuance of common stock and warrants | - | 1,073,589 | ||
| Cash flows provided by financing activities | $ | - | $1,111,089 | |
| Effect of exchange rate changes on cash | (580) | 728 | ||
| Decrease in cash | (3,226,817) | (553,636) | ||
| Cash, beginning of period | 3,326,851 | 1,154,901 | ||
| Cash, ending of period | $100,034 | $601,265 | ||
| Supplemental cash flow information: | ||||
| Cash paid for interest | $11,104 | $4,898 | ||
| Cash paid for taxes | - | - | ||
| Non-cash Investing and Financing transactions: | ||||
| Common stock issued and issuable on acquisition of intangible asset | $772,247 | $ | - | |
| Obligation to issue stock for acquisition of intangible assets | $838,374 | $ | - | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.